|
000
| 01207nam 2200265za 4500 |
|---|
| 001 | 9.692198 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210723140153 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2009||||xxc|||||o f|0| 0 eng d |
|---|
| 020 | |a978-1-100-12682-1 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-33/2009E-PDF |
|---|
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 245 | 10|aGuidance document for industry - reporting adverse reactions to marketed health products |h[electronic resource] |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |cc2009. |
|---|
| 300 | |a65p.|bglossary, references, tables |
|---|
| 500 | |a"Canada Vigilance Program." |
|---|
| 590 | |a09-45|b2009-11-06 |
|---|
| 690 | 07|aAdverse effects|2gcpds |
|---|
| 775 | 08|tDocument d'orientation à l'intention de l'industrie - déclaration des effets indésirables des produits de santé commercialisés |w(CaOODSP)9.636448 |
|---|
| 794 | |tGuidance document for industry - reporting adverse reactions to marketed health products |w(CaOODSP)9.694177 |
|---|
| 795 | |tDraft guidance document for industry : |w9.688899 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s2944 KB|uhttps://publications.gc.ca/collections/collection_2009/sc-hc/H164-33-2009E.pdf |
|---|